Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review

Rodas, Justyne D.; Sorkhou, Maryam; George, Tony P.

doi:10.3390/brainsci13010036

Cited by 7 publications

(3 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast to 2 of 12 general SUD evidence, there was no effect on retention in treatment [20]. These findings are in line with another recent review, showing CM to be efficacious in producing cannabis use reductions and abstinence amongst individuals with a psychotic spectrum or major depressive disorder [21].…”

Section: Introductionsupporting

confidence: 83%

Contingency Management for Dually Diagnosed Inpatients with Psychosis

Docx,

Destoop,

Dom

2024

IJERPH

View full text Add to dashboard Cite

Contingency management (CM) is an evidence-based treatment method in substance abuse treatment. However, little is known about its efficacy in dually diagnosed patients with psychosis and in inpatient settings. Therefore, the aim of this study is to investigate the efficacy of CM for dually diagnosed patients with psychosis in an inpatient setting. Furthermore, we investigate the effect of the nature of the reward used (cash vs. prize) on the efficacy of CM. We made use of an 8-week fish-bowl CM intervention by means of a within-subject reversal design with three treatment phases (baseline—intervention—follow-up). Sixty-seven patients were included in this study, of whom thirty-four completed the protocol. The results show no effect of CM on abstinence nor an interaction with clinical or demographic variables. Cash money is as effective as prizes. Future research should further investigate the effect of psychosis and treatment setting on the efficacy of CM, with special attention for Patient Report Experience and Outcome Measures (PREM/PROM).

show abstract

Section: Introductionsupporting

confidence: 83%

Contingency Management for Dually Diagnosed Inpatients with Psychosis

Docx,

Destoop,

Dom

2024

IJERPH

View full text Add to dashboard Cite

show abstract

“…Moreover, by reinforcing the engagement of the mobile application, it increased the magnitude of usage by the iCC + CM group for a relatively nominal reinforcement. The benefit of contingency management, when employed appropriately, can provide clinical advantages over standard treatment or treatment without CM, as well as providing increased exposure to therapeutic options [ 56 ]. Future research should evaluate the effectiveness of monetary versus social/community feedback reinforcement on engagement and sustained usage [ 57 ].…”

Section: Discussionmentioning

confidence: 99%

Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF)

Buono

Larkin

Pham

et al. 2023

Cancers

View full text Add to dashboard Cite

Introduction: Neurofibromatosis Type 1 (NF1) is an autosomal dominant genetic condition in which chronic pain is a predominant issue. Given the rarity of the disease, there are limited psychosocial treatments for individuals with NF1 suffering with chronic pain. Using mobile applications can facilitate psychosocial treatments; however, there are consistent issues with engagement. Utilizing a mixed methodology, the current study evaluated the customized iCanCope mobile application for NF1 on increasing engagement through the usage of contingency management. Methods: A mixed methods study from a subset of data coming from a randomized clinical trial that occurred from January 2021 to August 2022 was undertaken. Two groups (iCC and iCC + CM) were exposed to the customized iCanCope mobile application in which engagement data were captured in real-time with daily check-ins for interference, sleep, mood, physical activity, energy levels, goal setting, and accessing article content (coping strategies). Additionally, semi-structured interviews were conducted to gain insight into the participants’ experience at the end of the trial. Results: Adults (N = 72) were recruited via NF patient advocacy groups. Significant differences were noted between the groups in total articles read (p = 0.002), goals achieved (p = 0.017), and goals created (p = 008). Additionally, there were significant differences observed between user-generated goals and those that were app recommended (p < 0.001). Both groups qualitatively reported positive feedback on the customized mobile application, indicating that continued usage and engagement of the mobile application were acceptable. Conclusions: Employing customized mobile applications for adults with NF1 along with contingency management can leverage self-managed pain treatments while providing auxiliary resources to this population.

show abstract

“…Psychotherapies, such as cognitive-behavioral therapy (CBT) and motivational enhancement therapy (MET), reduce cannabis use in the short-term, although the effects of treatment tend to wane over time [15]. Contingency management for cannabis addiction has also been shown to be effective at reducing use and increasing abstinence rates on its own or in combination with CBT and MET, including for those diagnosed with comorbid psychotic or depressive disorders [16]. Although these interventions have short-term efficacy, treatment options for CUD are limited, and many individuals do not benefit from existing treatments.…”

Section: Introductionmentioning

confidence: 99%

Neuromodulation for Cannabis Use: A Scoping Review

Ngoy,

Tang,

Xiao

et al. 2024

Brain Sciences

Self Cite

View full text Add to dashboard Cite

This scoping review explores the use of neuromodulation techniques in individuals with cannabis use. Our goal was to determine whether cannabis use alters cortical excitation and inhibition in the context of neuromodulation and to determine whether neuromodulation affects craving and cannabis use patterns. A systematic search was conducted using PubMed, OVID Medline, and PsycINFO from inception to 20 December 2022. Our review identified ten relevant studies, eight of which used Transcranial Magnetic Stimulation (TMS), while two employed Transcranial Direct Current Stimulation (tDCS). Findings from TMS studies suggest that cannabis users exhibit altered cortical inhibition, with decreased short interval intracortical inhibition (SICI) compared to non-users. Single sessions of rTMS did not have any impact on cannabis craving. By contrast, two studies found that multiple sessions of rTMS reduced cannabis use, but these changes did not meet the threshold for statistical significance and both studies were limited by small sample sizes. The two included tDCS studies found contradictory results, with one showing reduced cannabis craving with active treatment and another showing no effect of active treatment on craving compared to sham. Future studies should further explore the effects of multiple treatment sessions and different neuromodulation modalities.

show abstract

Contingency Management for Treatment of Cannabis Use Disorder in Co-Occurring Mental Health Disorders: A Systematic Review

Cited by 7 publications

References 46 publications

Contingency Management for Dually Diagnosed Inpatients with Psychosis

Contingency Management for Dually Diagnosed Inpatients with Psychosis

Maintaining Engagement in Adults with Neurofibromatosis Type 1 to Use the iCanCope Mobile Application (iCanCope-NF)

Neuromodulation for Cannabis Use: A Scoping Review

Contact Info

Product

Resources

About